Using artificial intelligence (AI) in colonoscopy proved beneficial in terms of higher adenoma detection rates and lower rates of missed adenomas in comparison with the conventional diagnostic procedure. The computer-aided detection was particularly helpful in the discovery of small and very small adenomas.
“Up to a fourth of all adenomas are missed during colonoscopy, which potentially results in post-colonoscopy colorectal cancers,” Dr Michiel Maas (Raboud UMC, the Netherlands) said . To further explore possibilities to improve this situation, Dr Maas and colleagues designed an international, multicentre, randomised-tandem trial to evaluate the potential enhancement of polyp detection by using AI in colonoscopy. In 2 different groups, 916 patients with a mean age of about 60 years underwent a colonoscopy with or without use of the MAGENTIQ-COLO™ study device (magentiq.com). “A subset of patients was further randomised to undergo a tandem colonoscopy, so either a conventional colonoscopy followed by AI colonoscopy or vice versa,” Dr Maas explained. The primary outcome measure was adenoma per colonoscopy (APC). Secondary objectives were the adenoma detection rate (ADR) and adenoma miss rate. Reasons for the colonoscopy in the conventional group and computer-aided detection group were surveillance (44.2% and 43.1%, respectively) and non-immunological faecal occult blood test (55.8% and 56.9%, respectively).
The results showed a statistically significant APC rate for the computer-aided detection compared with the conventional group (0.70 vs 0.51; P=0.014). The ADR was also superior with computer-aided detection; not only in the entire cohort (37% vs 30%; P=0.014) but also for both indications: surveillance (P=0.001) and non-immunological faecal occult blood test (P=0.014). Dr Maas conveyed that the adenoma miss rate was almost halved with computer-aided detection (19%) in comparison with conventional colonoscopy (36%), while withdrawal times without intervention were equal in both groups.
In terms of adenoma characteristics that aided in better detection with computer-aided detection, size mattered. “We found an increased detection of diminutive adenomas sized ≤5 mm, but we also found an increase in small adenomas sized 6–9 mm in the computer-aided detection group compared with the conventional group. There were no differences in the detection of advanced adenomas or sessile serrated lesions,” Dr Maas stated. Furthermore, computer-aided detection found more adenomas in the proximal colon (P=0.006).
“This study further emphasises the beneficial role of AI or computer-aided detection in improving our detection rates in a regular screening and surveillance population,” Dr Maas concluded.
- Maas MHJ, et al. A novel computer-aided polyp detection system in daily clinical care: an international multicentre, randomised, tandem trial. LB06, UEG Week 2022, 8–11 October, Vienna, Austria.
Copyright ©2022 Medicom Medical Publishers
« Benefit of colon cancer screening with colonoscopy lower than anticipated Next Article
Immunotherapy response may be modulated by microbiome »
Table of Contents: UEGW 2022
Letter from the Editor
UEGW 2022 Highlights Podcast
IBD in 2022
Fast recapture of response with ozanimod after withdrawal in UC
Ozanimod treatment prompted substantial response after failure of response to induction
Etrasimod shows advantage over placebo in UC
Etrasimod reduces adaptive immune cells in the periphery in UC
Favourable maintenance rates for risankizumab also in delayed responders with CD
IL-23 inhibition reduces inflammatory biomarkers in pre-treated UC
Maintained symptom control with mirikizumab in UC
Mirikizumab successfully resolves active histologic inflammation in UC
Upadacitinib for CD: remarkable efficacy in induction therapy
Sustained maintenance results with upadacitinib in UC
Start low with brepocitinib and ritlecitinib in UC
Another chance for TYK2 inhibition in UC
Small molecule obefazimod shows promise in UC
Pivotal results of etrolizumab for CD partly disappointing
Better results for vedolizumab in early CD
Some patients with limited CD may benefit from an early surgical intervention
Dose-interval of adalimumab might be prolonged in CD patients in stable remission
What Is Hot in Upper GI Disorders?
Less ulcer bleeds early after H. pylori eradication in aspirin users
Dupilumab effective in paediatric patients with eosinophilic oesophagitis
Neoplasia in Barrett’s oesophagus: the earlier the intervention, the better the long-term outcome
Hepatology in 2022
Favourable pancreatitis outcomes with procalcitonin-based algorithm to guide antibiotic use
Portal hypertension is associated with poor prognosis in cirrhotic patients
Chances of transplant-free survival in PSC enhanced by colectomy with ileostomy
SARS-CoV-2: Booster doses of key importance for cirrhotic patients
What Is New in Pancreatic Cancer and Pancreatitis?
Fewer long-term interventions after delayed drainage in necrotising pancreatitis
Detection of Europe´s deadliest cancer: much room for improvement
Colorectal Carcinoma: Improving Diagnosis and Therapy
Immunotherapy response may be modulated by microbiome
Computer-aided colonoscopies improved adenoma detection rates
Screening-detected colorectal cancers may have superior surgical outcomes
ESMO 2021 Highlights Podcast